$ONCY

$0.49▲ -2.0% YTD

5 SEC 13D/G filings tracked · Last updated Oct 20, 2026

Filing History

CP $0.49▲ -2.0%Oct 20, 2026 · ThinkSabio Blog

$ONCY - Oncolytics Biotech® to Present REO 033 Trial in Progress Abstract at ESMO Showcasing Pelareorep’s Potential in Colorectal Cancer…

News

ONCY ▼ -8.2% - Oncolytics Biotech Inc.

CP $0.45▲ -8.2%Oct 14, 2026 · ThinkSabio Blog

$ONCY - Oncolytics Biotech® Provides Update on GOBLET Study Clinical Data and Final PanCAN Grant Payment…

News

ONCY ▼ -8.9% - Oncolytics Biotech Inc.

CP $0.51▲ -8.9%Oct 12, 2026 · ThinkSabio Blog

$ONCY - Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update…

News

ONCY ▲ +1.5% - Oncolytics Biotech Inc.

CP $0.67▲ +1.5%Sep 29, 2026 · ThinkSabio Blog

$ONCY - Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Im…

News

ONCY ▲ +5.0% - Oncolytics Biotech Inc.

CP $0.84▲ +5.0%Sep 10, 2026 · ThinkSabio Blog

$ONCY - Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer…